Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2381482, 11 pages
https://doi.org/10.1155/2017/2381482
Research Article

MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39

General Surgery Department, Tianjin First Central Hospital, Tianjin 300192, China

Correspondence should be addressed to Rende Guo; moc.621@2190edneroug

Received 10 August 2016; Revised 18 November 2016; Accepted 8 December 2016; Published 19 January 2017

Academic Editor: Tobias Kiesslich

Copyright © 2017 Rende Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA: A Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA: A Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Cameron, T. S. Riall, J. Coleman, and K. A. Belcher, “One thousand consecutive pancreaticoduodenectomies,” Annals of Surgery, vol. 244, no. 1, pp. 10–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Cai, Y. An, N. Lv et al., “miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2,” Oncology Reports, vol. 29, no. 5, pp. 1769–1776, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Li, N. Omura, S.-M. Hong et al., “Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels,” Cancer Research, vol. 70, no. 13, pp. 5226–5237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Jones, X. Zhang, D. W. Parsons et al., “Core signaling pathways in human pancreatic cancers revealed by global genomic analyses,” Science, vol. 321, no. 5897, pp. 1801–1806, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Z.-L. Zhang, Z.-H. Bai, X.-B. Wang, L. Bai, F. Miao, and H.-H. Pei, “MiR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells,” PLoS ONE, vol. 10, no. 3, Article ID e0118814, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. T.-C. Chang, E. A. Wentzel, O. A. Kent et al., “Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis,” Molecular Cell, vol. 26, no. 5, pp. 745–752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Farhana, M. I. Dawson, and J. A. Fontana, “Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells,” Cancer Biology & Therapy, vol. 16, no. 1, pp. 115–124, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. R. R. Chivukula, G. Shi, A. Acharya et al., “An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration,” Cell, vol. 157, no. 5, pp. 1104–1116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Taipaleenmäki, G. Browne, J. Akech et al., “Targeting of Runx2 by miR-135 and miR-203 impairs progression of breast cancer and metastatic bone disease,” Cancer Research, vol. 75, no. 7, pp. 1433–1444, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Forno, S. Ferrero, M. V. Russo et al., “Deregulation of MiR-34b/Sox2 predicts prostate cancer progression,” PLoS ONE, vol. 10, no. 6, Article ID e0130060, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-Y. Zhang, J.-H. Li, G. Li, and S.-R. Wang, “Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer,” Oncology Reports, vol. 34, no. 3, pp. 1193–1202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Shi, L. Zhan, C. Xiao et al., “miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer,” Oncotarget, vol. 6, no. 22, pp. 19043–19054, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Gal, G. Pandi, A. A. Kanner et al., “MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells,” Biochemical and Biophysical Research Communications, vol. 376, no. 1, pp. 86–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Bandres, N. Bitarte, F. Arias et al., “microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells,” Clinical Cancer Research, vol. 15, no. 7, pp. 2281–2290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Redova, A. Poprach, J. Nekvindova et al., “Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma,” Journal of Translational Medicine, vol. 10, no. 1, article 55, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. Â. Ribeiro-dos-Santos, A. S. Khayat, A. Silva et al., “Ultra-deep sequencing reveals the microRNA expression pattern of the human stomach,” PLoS ONE, vol. 5, no. 10, Article ID e13205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Godlewski, M. O. Nowicki, A. Bronisz et al., “MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells,” Molecular Cell, vol. 37, no. 5, pp. 620–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Tian, Y. Nan, L. Han et al., “MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma,” International Journal of Oncology, vol. 40, no. 4, pp. 1105–1112, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Martinez-Useros and J. Garcia-Foncillas, “Can molecular biomarkers change the paradigm of pancreatic cancer prognosis?” BioMed Research International, vol. 2016, Article ID 4873089, 13 pages, 2016. View at Publisher · View at Google Scholar
  24. A. Markou, E. G. Tsaroucha, L. Kaklamanis, M. Fotinou, V. Georgoulias, and E. S. Lianidou, “Prognostic value of mature MicroRNA-21 and MicroRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR,” Clinical Chemistry, vol. 54, no. 10, pp. 1696–1704, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. L.-X. Yan, X.-F. Huang, Q. Shao et al., “MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis,” RNA, vol. 14, no. 11, pp. 2348–2360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Slaby, M. Svoboda, P. Fabian et al., “Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer,” Oncology, vol. 72, no. 5-6, pp. 397–402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Hui, C. How, E. Ito, and F.-F. Liu, “Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies,” BMC Cancer, vol. 11, article no. 500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Fu, Y. Han, Y. Wu et al., “Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis,” European Journal of Clinical Investigation, vol. 41, no. 11, pp. 1245–1253, 2011. View at Publisher · View at Google Scholar
  29. X. Wei, W. Wang, L. Wang et al., “MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4,” Cancer Medicine, vol. 5, no. 4, pp. 693–702, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,” Annals of Internal Medicine, vol. 151, no. 4, pp. W-65–W-94, 2009. View at Google Scholar · View at Scopus
  31. M. Gironella, M. Seux, M.-J. Xie et al., “Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16170–16175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Godlewski, A. Bronisz, M. O. Nowicki, E. A. Chiocca, and S. Lawler, “microRNA-451: a conditional switch controlling glioma cell proliferation and migration,” Cell Cycle, vol. 9, no. 14, pp. 2742–2748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Konishi, D. Ichikawa, S. Komatsu et al., “Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma,” British Journal of Cancer, vol. 106, no. 4, pp. 740–747, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Redova, A. Poprach, J. Nekvindova et al., “Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma,” Journal of Translational Medicine, vol. 10, no. 1, article no. 55, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Nan, L. Han, A. Zhang et al., “MiRNA-451 plays a role as tumor suppressor in human glioma cells,” Brain Research, vol. 1359, pp. 14–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Dudkin, M. B. Dilling, P. J. Cheshire et al., “Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition,” Clinical Cancer Research, vol. 7, no. 6, pp. 1758–1764, 2001. View at Google Scholar · View at Scopus